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any aspects of human physiology and behavior
are dominated by 24-hour rhythms that have a major
impact on our health and well-being. For example, sleep-
wake cycles, alertness and performance patterns, core
body temperature rhythms, and the production of hor-
mones such as melatonin and cortisol are all regulated by
an endogenous near-24-hour oscillator in the suprachi-
asmatic nuclei (SCN) of the anterior hypothalamus. The
cells in these nuclei spontaneously generate rhythms with
a period close to, but not exactly, 24 hours, and in order
for the circadian pacemaker to ensure that physiology
and behavior are appropriately timed to anticipate events
in the outside world, environmental time cues must be
able to reset this internal clock to 24 hours. The major
environmental time cue that resets these rhythms in
mammals is the 24-hour light-dark cycle generated by the
earth’s axial rotation. Light information is captured
exclusively by the eyes using specialized retinal photore-
ceptors and transduced directly to the SCN via a dedi-
cated neural pathway, the retinohypothalamic tract
(RHT). Each day the light-dark cycle resets the internal
clock, which in turn synchronizes the physiology and
behavior controlled by the clock.
The major biochemical correlate of the light-dark cycle
is provided by the pineal melatonin rhythm. Under nor-
mal light-dark conditions, melatonin is produced only
301
C l i n i c a l  r e s e a r c h
M
Copyright © 2007 LLS SAS.  All rights reserved www.dialogues-cns.org
Visual impairment and circadian rhythm 
disorders
Steven W. Lockley, PhD; Josephine Arendt, PhD, FRCPath;
Debra J. Skene, PhD
Keywords: blindness; circadian; melatonin; sleep; alertness; performance;
entrainment; non-24-hour sleep-wake disorder; advanced sleep phase syndro-
me; delayed sleep phase syndrome
Author affiliations: Division of Sleep Medicine, Brigham and Women’s Hospital,
Harvard Medical School, Boston, Mass, USA (Steven W. Lockley); Centre for
Chronobiology, School of Biomedical and Molecular Sciences, University of
Surrey, Guildford, UK (Josephine Arendt, Debra J. Skene)  
Address for correspondence: Steven W. Lockley, PhD, Division of Sleep Medicine,
Brigham and Women’s Hospital, Harvard Medical School, 221 Longwood Avenue,
Boston MA 02115 USA 
(e-mail: slockley@hms.harvard.edu)
Many aspects of human physiology and behavior are
dominated by 24-hour circadian rhythms that have a
major impact on our health and well-being, including
the sleep-wake cycle, alertness and performance pat-
terns, and many daily hormone profiles. These rhythms
are spontaneously generated by an internal “pace-
maker” in the hypothalamus, and daily light exposure
to the eyes is required to keep these circadian rhythms
synchronized both internally and with the external envi-
ronment. Sighted individuals take this daily synchro-
nization process for granted, although they experience
some of the consequences of circadian desynchrony
when “jetlagged” or working night shifts. Most blind
people with no perception of light, however, experience
continual circadian desynchrony through a failure of
light information to reach the hypothalamic circadian
clock, resulting in cyclical episodes of poor sleep and
daytime dysfunction. Daily melatonin administration,
which provides a replacement synchronizing daily “time
cue,” is a promising therapeutic strategy, although opti-
mal treatment dose and timing remain to be deter-
mined.   
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during the night, and provides an internal representation
of the environmental photoperiod, specifically night-
length.The synthesis and timing of melatonin production
requires an afferent signal from the SCN which projects
to the pineal gland via the paraventricular nucleus and
the superior cervical ganglion. Light exposure during the
night also inhibits melatonin production acutely and pro-
vides an indirect assessment of light input to the SCN via
the RHT (Figure 1).1-4 Given the close temporal rela-
tionship between the SCN and melatonin production, the
melatonin rhythm is often used as a marker of circadian
phase and the melatonin suppression response as a proxy
for RHT-SCN-pineal integrity and sensitivity.
The role of light in circadian entrainment
Under normal conditions, the vital importance of daily
light-dark exposure to entrain circadian rhythms is taken
for granted. For example, although not consciously per-
ceived, the ability to sleep at night and be awake in the day
is largely controlled by the circadian system, which pro-
motes sleep during the night and wakefulness during the
day via alterations in efferent signals from the SCN to
other hypothalamic areas controlling sleep-wake states.5
The difficulties associated with trying to sleep during the
day or be awake at night at the “wrong” circadian time is
readily observed in sighted people following rapid trans-
meridian travel (“jet lag”)6 or in night-shift workers.7 When
traveling across multiple time zones, or when changing
from a day to a night shift, the change in the timing of the
light-dark exposure is too rapid for the internal circadian
pacemaker to synchronize to immediately.A 12-hour shift
in sleep timing or time zone may take as long as 2 weeks
to become resynchronized to,8 and often shift times or the
time zone are changed again before adaptation has
occurred. Consequently, the individual’s sleep pattern
becomes desynchronized from the circadian system and,
in the case of shift workers, daytime sleep duration is short,
sleep efficiency is poor, and night-time waking alertness
and performance are impaired,9 accounting for the high
incidence of accidents and injuries experienced by night-
shift workers.10 Other functions also become desynchro-
nized under such conditions, for example, postprandial
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Selected abbreviations and acronyms
11-OHCS 11-hydroxycorticosteroid
aMT6s 6-sulphatoxymelatonin
LP light perception
NPL no conscious perception of light
RHT retinohypothalamic tract
SCN suprachiasmatic nuclei
Figure 1. Neuroanatomy of the circadian system. Light is detected by spe-
cialized retinal photoreceptors and transduced to the circadian
pacemaker in the hypothalamic suprachiasmatic nuclei (SCN)
via the monosynaptic retinohypothalamic tract (RHT). SCN effer-
ents project to the pineal gland via the paraventricular nucleus
(PVN) and the superior cervical ganglion (SCG). Under normal
light-dark conditions, the pineal melatonin rhythm peaks at
night during the dark phase with the duration of melatonin pro-
duction reflecting the scotoperiod (night-duration) (top panel).
When the eyes are exposed to light at night, however, mela-
tonin production is immediately suppressed, recovering once
the light is switched off (middle panel). The “melatonin sup-
pression test” confirms the functional integrity of the retina-RHT-
SCN-PVN-SCG-pineal pathway. In individuals in whom the upper
spinal cord has been severed, for example in tetraplegic patients,
the signal from the SCN cannot reach the pineal gland and no
rhythmic production of melatonin is possible (lower panel).
Circadian rhythms in other parameters that do not require the
SCN-SCG pathway, such as cortisol and TSH rhythms, remain
fully intact in tetraplegic patients.1,2
Adapted from reference 3: Wehr TA, Duncan WC Jr, Sher L, et al. A cir-
cadian signal of change of season in patients with seasonal affective dis-
order. Arch Gen Psychiatry 2001;58:1108-1114. Copyright © American
Medical Association 2001; and from reference 4: Zeitzer JM, Ayas NT, Shea
SA, Brown R, Czeisler CA Absence of detectable melatonin and preser-
vation of cortisol and thyrotropin rhythms in tetraplegia. J Clin Endocrinol
Metab. 2000;85:2189-2196. Copyright © Endocrine Society 2000
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metabolism.When meals are taken during the biological
night, they cannot be metabolized as efficiently as when
eaten during the day, and consequently postprandial lev-
els of glucose, insulin, and fats are elevated.11-13 In the long
term, the regular impairment of metabolism induced over
years of shiftwork may lead to chronically elevated circu-
lating levels of insulin and fat, and may increase the risk of
developing insulin resistance, diabetes, or cardiovascular
disease.14 Gastrointestinal discomfort is also a common
complaint in jet lag,15 most likely due to the temporal mis-
alignment of circadian oscillators in peripheral tissues (eg,
the liver, kidney, esophagus, and stomach) that have
recently been identified (for review see ref 16).
The potential importance of light in human circadian
entrainment was first explored in cave experiments,
where investigators measured rhythms in physiology and
behavior when shielded from the solar day (although dim
artificial light was generally available).17,18 These studies
indicated that the circadian pacemaker did not oscillate
exactly on a 24-hour day, but had a circadian period (τ)
that was on average slightly longer than 24 hours. Studies
of subjects kept in temporal isolation,19 in dim light-dark
cycles,20,21 or on very long (eg, 28-h, 30-h, 42.85 h) or very
short (eg, 11-h, 20-h) day-lengths outside the range of
entrainment of the biological clock have also shown that
the period of the circadian clock is not exactly 24 hours
in humans (average ~24.2 h)22,23 similarly to that in other
mammals. Under such nonentrained conditions, the
rhythms controlled by the circadian system “free-run” at
the endogenous period of the biological clock. For exam-
ple, if a person’s nonentrained period is 24.5 h, the sleep-
wake cycle and other rhythms will also cycle with a
period of 24.5 h and the subject will therefore go to sleep
0.5 hours later each day, when measured using the 24-
hour clock (see below).
Real-world environments where altered light-dark expo-
sure can result in circadian desynchrony in sighted indi-
viduals include submarines, where the dim light levels
and rapidly rotating duty cycles cause the circadian sys-
tem to “free-run” with a non-24-hour cycle24; during
spaceflight, where unusual light-dark exposure, combined
with imposed non-24-hour “workdays,” cause disruption
to circadian rhythms and sleep25,26; and during polar win-
ters where, in the absence of any environmental light-
dark cycle, inadequate or poorly timed artificial light
exposure can fail to entrain circadian rhythms in sleep,
performance, and metabolism.27-29 Although the light-dark
cycle is the primary environmental time cue,“nonphotic”
time cues, such as sleep, exercise, food, and some drugs,
are also able to reset the circadian pacemaker (for review
see ref 30), and are potentially important for blind
patients (see below).
The effect of visual impairment 
on circadian entrainment
Early studies of hormone rhythm disorders in the blind
If ocular light exposure is the most important environ-
mental circadian synchronizer, the obvious question is,
what happens to the circadian rhythms in visually
impaired people? Abnormal hormonal patterns have been
reported in some visually impaired patients for more than
five decades. In the 1940s, Remler recognized that some
blind patients had normal 24-hour rhythms whereas some
had inverted rhythms in rectal temperature, heart rate,
blood pressure, and urinary excretion (194831 cited in
Hollwich and Dieckhues32). Subsequently, Orth and
Island,33 Kreiger and Rizzo,34 Bodenheimer et al,35 and
D’Allessandro et al36 all found irregularities in the plasma
profiles of corticosteroid production in a majority of blind
subjects. Orth and Island33 studied three subjects with no
conscious perception of light (NPL) and demonstrated a
normal, an abnormal, and a free-running rhythm of 17-
hydroxycorticosteroid (17-OHCS) production in these
subjects. Kreiger and Rizzo34 showed that five out of seven
blind subjects with light perception (LP) and nine of 12
NPL subjects had abnormal 11-hydroxycorticosteroid (11-
OHCS) rhythms. Similarly, Bodenheimer et al35 reported
that grouped data of 24-h cortisol measurements from
seven NPL subjects showed a phase difference compared
with sighted controls. D’Allessandro et al36 presented
mean plasma cortisol data from 11 NPL patients that did
not show 24-h rhythmicity.All the studies emphasized the
importance of light in modulating the secretion of corti-
costeroids and noted a split of these rhythms from the
sleep-wake cycle. Similarly, irregularities of sleep and its
timing were related to an abnormal phase of rectal tem-
perature.37,38 The rhythm of excretion rates of electrolytes
(Na+, Cl-, K+) was also shown to be abnormally timed
with a reduced amplitude in the blind.39,40
Several early studies did not find any irregularities in the
rhythms of blind individuals, however. Migeon et al41
failed to find any differences in the diurnal pattern of
plasma and urinary excretion of 17-OHCS between
sighted subjects, night workers, and blind subjects with
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no conscious light perception (NPL), although a reduc-
tion in the amplitude of plasma 17-OHCS was observed
in the blind people.Weitzman et al42 found normal corti-
sol and growth hormone rhythms in seven NPL subjects
comparable to sighted individuals. Similarly, Scheving et
al43 found no phase difference in the epinephrine and
norepinephrine rhythms of 14 blind subjects compared
with sighted subjects, although there was an increase in
the mesor of norepinephrine levels in these subjects.
A large study of the “endocrine system” of several hun-
dred blind individuals was conducted by Hollwich and
Dieckhues.32 They found abnormalities in a wide variety of
biochemical measurements in totally blind subjects
(n=220) compared with those with severely impaired
vision (n=140) and sighted subjects (n=50).These changes
included reduced serum levels of glucose, protein, cortisol,
sodium, and raised levels of creatinine and potassium
which were mirrored in urinary analysis. Unfortunately,
samples were taken only once or overnight, and did not
take into account any age or circadian phase differences
between individuals.They did postulate the existence, how-
ever, of an “excitatory effect” of light on the hypothalamus
via an “energetic pathway of the optic system, ...indepen-
dent of the visual pathway” that stimulated “releasing fac-
tors” from the hypothalamus that regulated hormone lev-
els, an observation that correctly anticipated confirmation
of a physiologically distinct retinohypothalamic tract.
Hollwich and Dieckhues also concluded that the reduction
in metabolic activity in the blind accounted for the com-
plaints of blind patients (including diminished physical
capacity, insomnia, autonomic and emotional disturbances,
desynchrony, and circadian rhythm sleep disorders).The
failure to follow circadian rhythms longitudinally within
individuals, however, limited the interpretation of these
early studies.
The first report of melatonin rhythms in the blind was
made by Smith and colleagues who showed that four blind
men had higher day- than night-time melatonin levels,44
the opposite of what would be expected in sighted subjects
(Figure 1). Subsequently, Lewy and Newsome45 investi-
gated plasma melatonin profiles in 10 blind subjects (9
NPL, 1 LP) and showed that six subjects had an abnor-
mally timed melatonin rhythm, three of these being phase-
advanced and three being phase-delayed. Longitudinal fol-
low-up of two of these patients showed one subject with a
stable but abnormally entrained melatonin rhythm (peak
time 10.00-12.00 h, an approximate delay of 8 hours com-
pared with normal) and the other subject had a free-run-
ning melatonin rhythm with a period of 24.7 h.45 The same
group later conducted a more extensive longitudinal study
of the plasma melatonin rhythms in 20 NPL subjects,46 and
confirmed a heterogeneous distribution of melatonin
rhythm types.Three subjects had normally phased mela-
tonin rhythms, three were abnormally entrained, and 11
had free-running melatonin rhythms with periods ranging
from 23.86 to 25.08 h.46 The remaining three subjects
appeared to be arrhythmic.
Early studies of sleep disorders in the blind
Another prediction that can be made if light is important
for circadian entrainment is that sleep disorders would be
more prevalent in blind compared with sighted subjects,
or in those without light perception, as compared with
those with some degree of light perception. Several epi-
demiological studies have investigated these hypotheses.
Miles and Wilson first reported that 76% of blind subjects
with a range of visual loss complained of a sleep-wake dis-
order (n=50).47 Additionally, 40% of subjects recognized
that the symptoms were cyclic or episodic, an important
characteristic of circadian rhythm sleep disorders (see
below). Sasaki et al48 demonstrated a lower incidence of
sleep-wake complaints (40%) in 73 blind teenagers,
although they did postulate that an increase in sleep dis-
order (delayed sleep phase syndrome and non-24-h sleep-
wake rhythm) was associated with a decrease in light per-
ception. More recently, Leger et al49 reported on the results
of a postal study in ~800 blind individuals, who were age,
sex- and location-matched with sighted controls. Overall,
significantly more of the blind individuals were said to
have at least one sleep disorder (83%—at least one of
latency, night-time and early-morning awakenings, reduced
sleep duration or quality) and in addition, 17% of the sub-
jects fulfilled the criteria for diagnosis of free-running sleep
patterns.50 Unfortunately, no information was provided
about the severity of visual loss in individuals with “free-
running” sleep or on any relationship between sleep dis-
order and visual acuity.A similar-sized postal study of UK
guide-dog owners (n=1139) was also conducted in the UK
by Moseley et al51 who reported a low prevalence of sub-
jective disorder overall (18%) which reduced to 14% in
subjects who did not report being depressed (n=981).The
methodology for sleep assessment was not described, and
the authors stated that sleep disorders were likely to be
due to other factors than circadian rhythm disorders
caused by loss of light perception.
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In order to address whether sleep disorders were associ-
ated with loss of light perception, we conducted a survey
of 388 registered blind individuals with a range of visual
acuities (n=54 with no perception of light [NPL] and
n=330 with visual acuity from 20/200 vision to light per-
ception only [LP]).52 Sleep disorders were assessed using
the Pittsburgh Sleep Quality Index (PSQI score > 5) and
subjects with depressive symptoms were excluded.
Disturbance of sleep was recorded in nearly 50%
(189/388) of the blind subjects overall. The prevalence
was higher (66%) and the sleep disturbance was more
severe (mean PSQI ± SD = 8.1 ± 1.1); however, in the
NPL group compared with those blind subjects with a
visual acuity of LP or better (46%, mean PSQI =5.8 ±
0.4), or sighted controls (9%, mean PSQI =2.9 ± 0.5;
n=44).52 These data are consistent with the hypothesis
that reduced photic input to the circadian pacemaker
may increase the risk of circadian rhythm sleep disorders.
Circadian rhythm disorders in the blind
The first study to describe conclusively that circadian
rhythm disorders per se occurred in the blind was con-
ducted by Miles et al in 1977.53 They showed that a blind
man with no conscious perception of light (NPL) had
nonentrained “free-running” sleep-wake, temperature,
alertness, performance, cortisol and urinary excretion
rhythms with a period (τ) of 24.9 hours when the subject
lived freely without restriction. Similarly, Orth et al54
demonstrated a free-running cortisol rhythm with a
period of 24.5 h in a 52-year-old woman with NPL, and
other cases reported similar results in sleep and/or hor-
monal rhythms.55-59 These periodicities persisted despite
attempts to entrain the rhythms using a strict regime of
bedtime, meals, and activity, or knowledge of clock time.
In order to extend these findings, in 1994 we started a
series of studies to investigate in more detail the rela-
tionship between visual impairment and circadian
rhythm disorders under real-world conditions.60-62 To date,
we have studied 67 blind adults (aged 17 to 74 years; 48
males, 19 females) with varying visual acuities using a
home-based protocol where subjects are asked to main-
tain a daily sleep log for at least 4 weeks, and wear an
activity monitor continuously.63 For 48 hours per week,
most subjects are also asked to rate their alertness and
mood every 2 hours while awake using four 9-point
Likert scales, and complete a four-choice serial auditory
reaction time test after each alertness rating. Finally, they
are asked to collect their urine for the same 48 hours in
4-hourly episodes while awake plus an 8-hourly collec-
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Figure 2. Characterizing circadian phase using urinary aMT6s rhythms.
Examples of urinary aMT6s rhythms measured for 48 hours over
4 consecutive weeks are shown for three representative blind
subjects. Panel A shows a normally entrained aMT6s rhythm
with a normal night-time peak (grey bar, normal range 1:00-
7:00 h), that remains remarkably stable from week to week,
despite the study being conducted by the subject at home. A
proportion of subjects exhibit stable 24-hour rhythms but are
entrained to an abnormally advanced or delayed phase. Panel
B shows an advanced subject who has an aMT6s rhythm peak-
ing relatively early compared with normal. Panel C shows the
most common rhythm type observed in subjects with no con-
scious perception of light (NPL), namely a nonentrained “free-
running” rhythm. While the rhythm may initially appear arrhyth-
mic, closer inspection shows that the aMT6s peak is changing
from week to week over the 4-week study (W1-W4), getting
relatively later each week, and thereby exhibiting a circadian
period >24 hours (τ=24.7 h in this case). In these cases, longi-
tudinal assessment over several weeks or even months, if the
endogenous period is very close to 24 hours, is required to dis-
tinguish the nonentrained rhythm from a normally or abnor-
mally entrained stable rhythm.  
Adapted from reference 64: Skene DJ, Lockley SW, James K, Arendt J.
Correlation between urinary cortisol and 6-sulphatoxymelatonin rhythms
in field studies of blind subjects. Clin Endocrinol. 1999;50:715-719.
Copyright © Blackwell Publishing 1999
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tion overnight, record the volume by weight, and retain
a sample for analysis.The urine samples are analyzed for
6-sulphatoxymelatonin (aMT6s) (Figure 2),64 the major
urinary metabolite of melatonin, or cortisol, which pro-
vide a reliable marker of circadian phase.27,64-66
The incidence of circadian rhythm disorders is related to
the degree of visual acuity. Of the 30 individuals with
light perception (LP; 19 males, 11 females), 77% had nor-
mally entrained aMT6s rhythms, and four (13%) had
abnormally phased rhythms (2 advanced and 2 delayed).
Two subjects had no detectable rhythm and one subject
with minimal LP in one eye only exhibited a free running
aMT6s rhythm (τ = 24.62 h). Conversely, the majority of
NPL subjects (76%) had abnormal aMT6s rhythms
(either abnormally entrained or “free running”). Of those
NPL subjects with at least one eye, 11 (46%) had free-
running aMT6s rhythms (τ range = 23.92-24.79 h), 5
(21%) were abnormally phased (3 advanced, 2 delayed)
and 7 (29%) were normally entrained. One subject had
no significant rhythm. One subject with small vestigial
eyes located under the skin (cryptophthalmos) also had
normal aMT6s and cortisol rhythms.All of the bilaterally
enucleated subjects (n=12) exhibited free-running
rhythms with periods ranging from 24.13 to 24.81 h.
Although abnormal timing of hormonal patterns can
confirm the presence of a circadian rhythm disorder,
patients complain about the resultant circadian rhythm
sleep disorder, and disturbed sleep is the most commonly
reported symptom associated with misaligned circadian
rhythms (Figures 3 and 4).62,67 Irregularities of sleep and
its timing were previously related to an abnormal phase
of the rectal temperature rhythm37,38 and in 1990, Martens
et al reported that 71% of NPL subjects (n=16) com-
plained of a chronic sleep disorder associated with
increased sleep episodes and increased daytime sleep.68
We have extended these findings and showed that sleep
depends on circadian phase,69 even under real-world con-
ditions.62 In entrained subjects, the timing of sleep was
highly correlated with the timing of the aMT6s rhythm
such that subjects with advanced aMT6s rhythms had a
relatively earlier sleep time and subjects with delayed
aMT6s rhythms had a later sleep time (Figure 4).62 In
“free-running” subjects, a more complicated pattern
emerges where sleep exhibits a non-24-hour pattern that
cycles in and out of synchrony with the 24-hour social
day on which most subjects try to live (Figure 3B). The
episode of poor sleep is characterized by short duration
night-time sleep and a high propensity for daytime naps,
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Figure 3. Circadian rhythms of sleep and melatonin in two blind subjects.
The left-hand panels show subjective sleep times (■) over 4 to 5
weeks, double-plotted according to time of day (abscissa) and
study day (ordinate). Subjects also collected sequential 4- to 8-
hourly urine samples for 48 hours per week and the peak time
of urinary 6-sulphatoxymelatonin (aMT6s) production each week
(O) is plotted. The right-hand panels show the weekly rhythms
of urinary aMT6s production (●) that correspond to the peak
times shown and the gray bars represent the normal range of
peak production for aMT6s (1:00-7:00 h). 
Panel A shows data from a visually impaired female aged 35
years with a visual acuity allowing her to detect hand movements
only and normal circadian rhythms (Subject 21). Both the sleep-
wake cycle and aMT6s rhythm remain entrained to 24 hours (A,
left panel) with normal night-time production of melatonin (A,
right panel) and such rhythms would be typical of most sighted
subjects. Note that her visual impairment, while severely dis-
rupting the visual system, does not affect the circadian photore-
ception system, illustrating the functional separation of the visual
and circadian photoreceptor systems. Panel B shows the rhythms
from a 66-year-old totally blind man with one eye and no con-
scious light perception (Subject 20). He exhibits a sleep-wake
cycle and melatonin rhythm that is not entrained to 24 hours.
The aMT6s rhythm exhibits a non-24-hour period (τ = 24.68 h)
which clearly delays from week-to-week and is not entrained to
the night (B, right panel). Similarly, the sleep pattern show a cyclic
sleep disorder characteristic of “non-24-hour sleep-wake disor-
der,” with recurrent episodes of disturbed night-time sleep and
many daytime naps when melatonin peaks during the day (eg,
Days 1 to 8, or 28 to 35) that alternate with episodes of good
sleep and high day-time alertness when the melatonin is pro-
duced during the night (eg, Days 10-25) (B, left panel). 
Reproduced from reference 68: Lockley SW. Human circadian rhythms:
influence of light on circadian rhythmicity in humans. In: Squire LR, ed
New Encyclopaedia of Neuroscience, Oxford, UK: Elsevier. In press.
Copyright © Elsevier 2007.
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the timing of which coincides with the aMT6s peak as the
circadian system drives sleepiness during the biological
(but not social) night.62,70 The cyclic sleep-wake pattern,
formally termed “non-24-hour sleep-wake disorder,”50
persists ad infinitum and can be extremely disruptive and
debilitating, especially in individuals with periods very
close to 24 hours, when sleep can remain misaligned from
the circadian cycle for many months.
In addition to affecting sleep, circadian rhythm disorders
also impact waking function. In addition to the high
propensity for naps during the day,70 subjects also rate
themselves more sleepy and more miserable and perform
worst when they are awake at an adverse circadian
phase.71 In entrained subjects, the daily profile of sleepi-
ness, mood, and performance depends on the circadian
phase of the wake episode, such that advanced subjects
feel better in the early part of the day and worse late in the
day, whereas delayed subjects report feeling very sleepy
for the first half of the day, but then gradually getting bet-
ter as the day goes on.These alertness and performance
profiles are similar to those experienced by extreme
“morning” and “evening” types who also sleep and wake
at relatively abnormal circadian phases.72 In free-running
subjects, the rhythms in alertness and performance also
free-run, as first shown in the case by Miles et al,53 such
that subjects report feeling the worst when awake at the
time of peak aMT6s production and best when awake at
a normal circadian phase, when no aMT6s is being pro-
duced, as occurs in most sighted subjects.
The effect of light in the blind
The effect of visual impairment on circadian 
photoreception
The impact of different types of visual impairment on the
circadian system has been used as an indirect method to
assess the photoreceptor systems mediating circadian
and other nonvisual responses to light. Firstly, these stud-
ies have shown that eyes are required for circadian pho-
toreception; individuals without eyes, either through
bilateral enucleation or as a result of developmental dis-
orders, are unable to entrain their circadian pacemaker
to the 24-hour light-dark cycle.61 Similarly, the majority
of totally blind individuals who retain their eyes but can-
not consciously perceive light also exhibit circadian
rhythms that are not entrained to the 24-hour light-dark
cycle, as described above.
Disorders of the visual system do not always attenuate the
circadian effects of light, however, demonstrating a func-
tional separation of the visual and circadian photorecep-
tion systems.As outlined previously, the majority of legally
blind individuals who retain some degree of light percep-
tion, even with very little usable vision in some cases, have
Figure 4. Relationship between sleep timing and circadian phase in entrained blind subjects. Panel A shows subjective sleep (■) and urinary 6-sulpha-
toxymelatonin rhythm (O) timing over 4 weeks (study day on ordinate axis, clock time on abscissa) in two blind subjects, one with advanced
sleep phase syndrome (ASPS) and one with delayed sleep phase syndrome (DSPS). In the ASPS subject, the advanced aMT6s peak (~20:00 h,
8 hours earlier than normal) is associated with many daytime naps in the late afternoon and early evening, as the circadian system attempts to
initiate sleep during the biological night, and an early wake-time from the main sleep episode. The DSPS subject exhibits a relatively delayed
sleep onset time on most days, but shows a particularly delayed sleep pattern during weekends when not having to set an alarm for work, as
on other days. Panel B shows the correlation between the timing of the aMT6s peak (abscissa) and sleep onset time (ordinate) in visually impaired
entrained subjects, illustrating the change in sleep timing associated with altered circadian phase. 
Adapted from reference 62: Lockley SW, Skene DJ, Butler LJ, Arendt J. Sleep and activity rhythms are related to circadian phase in the blind. Sleep. 1999;22:616-
623. Copyright © Associated Professional Sleep Societies 1999
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normally entrained circadian rhythms.61 Primary loss of the
central or peripheral visual fields is also not associated
with circadian rhythm disorders,61,63 suggesting that the cir-
cadian photoreceptor system is less sensitive to the spatial
distribution and intensity of light than vision. Color blind-
ness, a more specific lesion of the three-cone photopic
visual system, also does not attenuate circadian responses
to light, as measured by acute suppression of pineal mela-
tonin,73 suggesting that the cones are not the primary pho-
toreceptors mediating this response. Finally, and most
definitively, it has been demonstrated that a small pro-
portion of blind people without light perception retain
normal circadian phase-shifting and melatonin suppres-
sion responses to light, even in the absence of any func-
tional rods or cones, as assessed by conscious ability to
detect light, visually-evoked potentials, or electroretino-
gram (Figure 5).74,75 As expected if their eyes contained
fully functional circadian photoreceptors, these individu-
als exhibit normally entrained 24-hour rhythms under
real-world conditions and do not report sleep disorders.74
The effects of light in these subjects are mediated exclu-
sively via the eyes as, when their eyes are covered, the
effects of light are inhibited.Thus, circadian photorecep-
tion can be maintained in some humans in the absence of
a functional visual system, as has also been shown in trans-
genic and developmental rodent models of blindness (for
review see ref 76).While intact circadian photoreception
explains the normally entrained 24-hour rhythms in about
20% of entrained NPL subjects, most blind people who
exhibit 24-hour rhythms are not affected by light (63,
Lockley et al, unpublished results) and are either
entrained by nonphotic time cues (see below) or have a
period very close or equal to 24 hours.
Spectral sensitivity of circadian photoreception
The neuroanatomical basis and photoreceptor mecha-
nisms underlying the functional separation of visual and
Figure 5. Absence and presence of circadian photoreception in two totally blind subjects. Panels A and C: Subjects completed daily sleep and nap diaries
for ~11 to 12 weeks and their sleep times (solid lines) are double-plotted according to convention in Figure 3. Subjects also had their circa-
dian phase measured at regular intervals from either core body temperature minimum (O Panel A) or plasma melatonin onset (Δ Panel C). Panels
B and D show the results of a melatonin suppression test during which the subjects’ eyes were exposed to bright white light (6000 to 13 700
lux) for 90 to 100 minutes during plasma melatonin production.
Panels A and B show the sleep–wake pattern and melatonin suppression response for a 70-year-old blind man with congenital glaucoma. He
retained both eyes but reported no conscious light perception. Electroretinogram (ERG) and visually evoked potential (VEP) responses were not
detectable. As shown in Panel A, the subject’s circadian system was not entrained to the light-dark cycle and the core body temperature rhythm
exhibited a non-24-hour period. Consistent with the lack of entrainment by light, light exposure did not have any effect on the melatonin
rhythm, confirming that the retina-SCN-pineal pathway was not functional in this patient.
Panels C and D show the sleep-wake pattern and melatonin suppression results for a 21-year-old woman with Leber’s congenital amaurosis,
a type of retinal dystrophy. The ERG was undetectable but an abnormal VEP was recorded. As shown in Panel C, the sleep-wake cycle was nor-
mal with stable entrainment to 24 hours. The melatonin suppression response was clearly positive, with an immediate suppression of melatonin
at lights on (open bar) which ceased once the bright lights were switched off. Despite the subject’s lack of conscious light perception, light was
still able to stimulate the retina-SCN-pineal pathway; covering the eyes prevented the response. The normal sleep-wake cycle, coupled with the
positive melatonin suppression test, indicated that light was able to entrain the circadian system of this totally blind woman. Note: a similar
sleep-wake pattern but accompanied by a negative melatonin suppression test would indicate that (i) the subject was entrained to 24 hours by
a nonphotic time cues or (ii) the subject’s endogenous circadian period was exactly 24 hours. SCN, suprachiasmatic nucleus
Reproduced from reference 74: Czeisler CA, Shanahan TL, Klerman E., et al. Suppression of melatonin secretion in some blind patients by exposure to bright light.
N Engl J Med. 1995;332:6-11. Copyright © Massachusetts Medical Society 1995
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nonvisual responses to light have been discovered (for
reviews see refs 76,77). Briefly, a novel opsin, melanopsin,
has been located in specialized retinal ganglion cells that
are directly sensitive to light and project to the brain
areas mediating these nonvisual effects of light (eg, SCN
for circadian and melatonin responses, olivary pretectal
nuclei for pupil constriction responses). The cells are
most sensitive to short-wavelength (blue) light ~480 nm
and the absorption spectrum of melanopsin is distinct
from the absorption spectra for the rods or cones.
Animals that have had their melanopsin “knocked out”
can still retain some circadian responses to light, show-
ing that the traditional visual system likely contributes to
these effects, but the melanopsin-driven system appears
to be the primary phototransducer for the circadian
effects of light. Action spectra for the behavioral effects
of light in rodents and primates (eg, circadian phase
resetting, pupil constriction) also show a peak sensitivity
of ~480 nm, matching the cellular spectral sensitivity, as
do action spectra for melatonin suppression and pupil
responses in humans.78-80 Circadian phase resetting and
the alerting effects of light are also short-wavelength sen-
sitive in humans,81-86 suggesting that the novel non-rod,
non-cone photoreceptor system primarily mediates a
wide range of nonvisual effects of light. These findings
are consistent with those in blind humans described
above, who retain circadian responses to light despite
absent or attenuated rod and cone function.
The effect of nonphotic time cues in the blind
Although light is the most powerful environmental time
cue, nonphotic time cues are able to affect the circadian
pacemaker.30 In sighted subjects, the timing of sleep,87
exercise,88,89 and carbohydrate intake,90 but not knowledge
of clock time,91 have been shown to phase-shift the circa-
dian clock. Other potential nonphotic synchronizers
include social interaction and olfactory cues.30
In the absence of light input to the clock, nonphotic time
cues are obviously a potential therapeutic option to treat
non-24-hour circadian rhythms disorder in the blind.
There are currently no therapeutic guidelines, but some
preliminary research suggests that it may be beneficial
for patients to try to maintain a regular 24-hour sched-
ule. Klerman and colleagues92 showed that the circadian
system of a blind man with a period of 24.1 h became
entrained when he lived on a 23.8 h “day.”All aspects of
his schedule were shifted simultaneously in this protocol,
including the sleep-wake cycle, meal times, activity, pos-
ture, and interaction with staff, precluding identification
of the effective time signal, but collectively at least they
were able to induce a phase advance. Other attempts to
entrain circadian rhythms in blind people using a “poten-
tial complex zeitgeber,” including exercise (bicycle riding,
50 W over 15 mins), a strict social routine, a cold shower,
and a heavy protein breakfast37 appeared to have induced
a shift in the timing of sleep and temperature rhythms,
although it is not clear whether entrainment occurred.
The relative weakness of nonphotic time cues is readily
observed; however, in the majority of totally blind peo-
ple who are not entrained when living in society (see
above), where they are exposed to many 24-hour time
cues such as work or school schedules, mealtimes, sleep-
wake schedules, activity, alarm clocks, family and social
interaction, and so on. The inability to entrain to these
schedules is dependent on an individual’s intrinsic circa-
dian period as the weak nonphotic time cues with have
narrow “limits of entrainment,” the range of periods over
which nonphotic cues can have an effect. If an individ-
ual’s circadian period is too far from 24 hours, the weak
nonphotic time signals will be unable to entrain it.
Treatment of circadian rhythm disorders 
in the blind
While some other drugs have been shown to shift the
timing of the clock (for review, see ref 30) the most
promising therapeutic strategy for treatment of non-24-
hour sleep-wake disorder is daily administration of mela-
tonin.Although it was shown more than 20 years ago that
melatonin treatment could entrain free-running rhythms
in rats93 and could cause phase advance shifts in
humans,94,95 demonstration of entrainment in free-running
humans took longer to prove. Initial experiments using
daily treatment with 5 mg or higher doses either failed to
affect the circadian pacemaker at all56,96 or shortened
period without inducing entrainment.97,98 These and other
cases99-104 did report some improvement or stabilization
of the sleep-wake cycle in these patients,105 most likely
through the direct soporific effects of melatonin.105-108
In 1996, we began a re-examination of the entraining
effects of melatonin in seven men with non-24-hour
rhythms with a period >24 hours.109 Five subjects received
5 mg melatonin PO or placebo at 21:00 h each for a full
circadian beat cycle (35 to 71 days depending on their cir-
cadian period) and two additional subjects received
melatonin only in a single-blind design. Entrainment was
assessed using urinary cortisol rhythms.64 As their
endogenous rhythms were longer than 24 hours, subjects
required a daily phase advance (ie, a shift to an earlier
time) to become entrained to 24 hours.
Three of the subjects exhibited entrained cortisol rhythms
and one had a shortened period during treatment. The
remaining three subjects were not affected by melatonin.
Post-hoc analysis of melatonin treatment timing indicated
that those subjects who failed to entrain had treatment ini-
tiated at a time that corresponded to the delay phase of
the melatonin phase response curve (PRC)110 (equivalent
to ~1:00-13:00 h in a normally-entrained subject) where
melatonin causes a phase delay shift (ie, to a later time),
the opposite of that required to entrain. Surprisingly, the
subjects did not entrain once they free-ran into the correct
window to cause a phase advance, unlike previous animal
models.93 Those subjects who became entrained or had a
shortened period had their treatment initiated during the
phase-advance portion of the PRC (~13:00-1:00 h in nor-
mal subjects), a time consistent with the observed daily
advance achieved. We hypothesized at the time that the
inappropriate initial timing in the nonentrained subjects
may have affected the sensitivity to melatonin (for exam-
ple, by receptor downregulation) when the appropriate
treatment time was reached.
Shortly following publication of these data, similar results
were published by Sack and colleagues using a 10-mg
dose of melatonin initiated during the phase-advance
window, who also showed entrainment of plasma mela-
tonin rhythms when assessed during temporary suspen-
sions of melatonin treatment.111 In addition, they demon-
strated that the 10-mg dose could be gradually stepped
down to 0.5 mg and entrainment could be maintained.111
These data raised the question as to whether a 0.5-mg de
novo dose could also reset the clock, and both we and
others confirmed that it could.112-114 This low dose was also
more likely to entrain than treatment with higher doses
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Figure 6. Entrainment of circadian rhythms in the blind with melatonin. This Figure shows the double-plotted sleep timing (■) and urinary cortisol peak
times (O) for two totally blind men treated with 5 mg melatonin PO at 21:00 h for at least one circadian cycle in a placebo-controlled single-
blind design. Sequential study days are plotted on the ordinate and clock time is plotted on the abscissa. The start and end of placebo (Pla) and
melatonin (Mel) treatment are indicated by the boxes.
Panel A shows a subject who was entrained by melatonin treatment (S17). He exhibited a cortisol period of 24.3 h during placebo treatment
but was fully entrained (τ=24.0 h) at a normal circadian phase (mean ± SD cortisol peak time =9.9±0.7 h)67 during melatonin administration.
The stabilized sleep-wake cycle observed during melatonin treatment becomes immediately disrupted upon cessation of treatment and reverts
to the characteristic non-24-hour pattern, with cyclic episodes of good sleep at night and a small number of daytime naps followed by extremely
disrupted night-time sleep and excessive day-time napping.
Panel B shows a subject who failed to entrain to melatonin treatment (S45) and who exhibited similar periods during melatonin (25.2 h) and
placebo (24.9 h) administration, despite melatonin treatment for nearly two full circadian cycles. The persistent cyclic non-24-hour sleep dis-
order is apparent throughout both the placebo and melatonin treatment. 
Reproduced in part from ref 109: Lockley SW, Skene DJ, James K, Thapan K, Wright J, Arendt J. Melatonin administration can entrain the free-running circadian
system of blind subjects. J Endocrinol. 2000;164,:R1-R6. Copyright © Society for Endocrinology 2000
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(5 to 20 mg) maybe through providing a more discreet
time signal than a higher dose with a more prolonged
duration in the circulation. The individual circadian
period may also affect the likelihood of entrainment with
melatonin,115 as those subjects with periods furthest from
24 hours may be outside the range of entrainment for this
relatively weak time cue. Inconsistencies still exist, how-
ever, as to whether the circadian time of initial treatment
affects subsequent entrainment. In our studies, using both
5 and 0.5 mg melatonin, entrainment was more likely if
treatment was initiated in the advance, compared with
the delay, phase of the PRC in both between and within-
subjects designs (109,113, Lockley et al, unpublished results).
At low doses, however, (0.5 mg or lower), melatonin
treatment initiated at any circadian phase will eventually
cause entrainment of the circadian pacemaker,113-114,116
although there may be a delay until presumably the
phase-advance part of the PRC is reached. Current con-
sensus suggests, therefore, that smaller doses (up to 0.5
mg) may be preferable to larger doses, and that treat-
ment timing should be timed initially to phase advance if
possible (to achieve immediate entrainment [Figure 6])109
but if mistimed, may still eventually cause entrainment.
Given melatonin’s soporific properties, treatment should
also be given close to the desired bedtime to ensure the
alignment of the circadian and social day. Melatonin
administration has also been explored for treatment of
abnormal entrained phase disorders in the blind,117 as
well as sighted populations,118 but appropriate timing may
be even more important in these groups than non-24-
hour sleep disorder.119
Conclusion
The detrimental effects of loss of light perception, or loss
of eyes, on circadian rhythm entrainment, and subse-
quently sleep and waking function, are often inade-
quately recognized by physicians, families, friends, and
employers, making it difficult for blind people to obtain
the treatment and support required to deal with this
highly prevalent condition. Our data confirm the anec-
dotal accounts from subjects, who describe fighting to
stay awake at work, having problems maintaining con-
centration and memory during the day, or being over-
whelmed with a desire to sleep at inappropriate times.
These circadian rhythm sleep disorders are chronic, unre-
lenting, and currently difficult to manage with conven-
tional approaches. Simply treating the sleep-wake symp-
toms, for example with a combination of daytime stim-
ulants and night-time hypnotics, indicates an insufficient
diagnosis and a failure to address the underlying cause of
the condition. Correcting the underlying misalignment
between circadian and sleep-wake cycles, for example
using appropriately-timed melatonin treatment as
described above, is fundamental for the optimal treat-
ment of circadian rhythm sleep disorders.
Clinically, our data suggest that sleep disorders in visu-
ally impaired people with some degree of LP are not due
to circadian desynchrony, and should therefore be inves-
tigated for other sleep disorders as in sighted subjects.
Blind people with NPL who complain of sleep disorders,
particularly episodic or cyclic insomnia and daytime
sleepiness, should be studied longitudinally to confirm a
circadian disorder diagnosis, using home-based sleep
diary and urine assessments as described above.61,62 If
non-24-hour rhythms are confirmed, then treatment with
low-dose (0.5 mg) melatonin at a fixed clock time close
to bedtime is warranted.To enhance the chance of imme-
diate entrainment, treatment should commence once the
subject begins to slip out of a normal sleep phase, char-
acterized by difficulty initiating sleep (long sleep latency)
or difficulty getting up in the morning. In advanced or
delayed sleep phase syndrome, melatonin treatment tim-
ing should be individually determined based on the
extent of their abnormal phase according the melatonin
PRC110 and stepwise treatment for particularly advanced
or delayed subjects may be warranted. In all of these dis-
orders, daily melatonin treatment is a lifelong require-
ment, as once treatment is stopped, the circadian pace-
maker will revert to its endogenous period or phase
angle (Figure 6). The safety profile of melatonin, while
not assessed for very long-term use in humans, is
good,104,120,121 although care should be taken to ensure it is
from a reliable source and pharmaceutical grade. In the
near future, melatonin analogs will also become
approved for this indication although as with melatonin,
a correct initial diagnosis is required, and precise timing
and dose remain to be determined. ❏
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